HACKENSACK, NJ / ACCESSWIRE / March 12, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today announced its financial results for its third quarter of fiscal 2024, ended January 31, 2024. Third Quarter and Recent Highlights: Third quarter revenue of $12.0 million, a decline of 6% Gross margin declined to 35% College of... Read More